| ATYR PHARMA INC. DL -,001 |
| USA |
| Gesundheit |
| US0021202025 / A2PM86 |
| 471A (Frankfurt) / ATYR (NASDAQ) |
| FRA:471A, ETR:471A, 471A:GR, NASDAQ:ATYR |
| - |
| https://www.atyrpharma.co.. |
|
Atyr Pharma Inc. is a clinical-stage biotechnology company focused on discovering and developing first-in-class medicines derived from its proprietary tRNA synthetase platform. The company translates tRNA synthetase biology into therapies targeting f..
>Volltext.. |
| 72.27 Mio. EUR |
| 15.38 Mio. EUR |
| 0.16 Mio. EUR |
| -65.9 Mio. EUR |
| -64.21 Mio. EUR |
| -0.69 EUR |
| 10.42 Mio. EUR |
| 9.31 Mio. EUR |
| -53.7 Mio. EUR |
| 5.19 |
| -28.74% |
| -2.04% |
| - |
| - |
| - |
| - |
| ATYR |
| 05.04.26 |
|